Статті в журналах з теми "SA14-14-2 E"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "SA14-14-2 E".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Huang, Rong, Shengling Leng, Yalan Feng, Liping Tang, Lei Yuan, and Jian Yang. "Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14." Canadian Journal of Infectious Diseases and Medical Microbiology 2019 (March 3, 2019): 1–7. http://dx.doi.org/10.1155/2019/9179308.
Повний текст джерелаYe, Qing, Xiao-Feng Li, Hui Zhao, Shi-Hua Li, Yong-Qiang Deng, Rui-Yuan Cao, Ke-Yu Song, et al. "A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1’ formation and contributes to attenuation." Journal of General Virology 93, no. 9 (September 1, 2012): 1959–64. http://dx.doi.org/10.1099/vir.0.043844-0.
Повний текст джерелаKhou, Cécile, Marco Aurelio Díaz-Salinas, Anaelle da Costa, Christophe Préhaud, Patricia Jeannin, Philippe V. Afonso, Marco Vignuzzi, Monique Lafon, and Nathalie Pardigon. "Comparative analysis of neuroinvasion by Japanese encephalitis virulent and vaccine viral strains in an in vitro model of human blood-brain barrier." PLOS ONE 16, no. 6 (June 4, 2021): e0252595. http://dx.doi.org/10.1371/journal.pone.0252595.
Повний текст джерелаGromowski, Gregory D., Cai-Yen Firestone, and Stephen S. Whitehead. "Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice." Journal of Virology 89, no. 12 (April 8, 2015): 6328–37. http://dx.doi.org/10.1128/jvi.00219-15.
Повний текст джерелаLi, Guohua, Xianyong Meng, Zhiguang Ren, Entao Li, Feihu Yan, Jing Liu, Ying Zhang, et al. "Characteristics of Chimeric West Nile Virus Based on the Japanese Encephalitis Virus SA14-14-2 Backbone." Viruses 13, no. 7 (June 29, 2021): 1262. http://dx.doi.org/10.3390/v13071262.
Повний текст джерелаLiu, Zheng-le, S. Hennessy, B. L. Strom, T. F. Tsai, and S. B. Halstead. "Safety of live-attenuated Japanese encephalitis (JE) vaccine (SA14-14-2)." Journal of Clinical Epidemiology 50 (January 1997): S17. http://dx.doi.org/10.1016/s0895-4356(97)87218-6.
Повний текст джерелаYang, Dong, Xiao-Feng Li, Qing Ye, Hong-Jiang Wang, Yong-Qiang Deng, Shun-Ya Zhu, Yu Zhang, Shi-Hua Li, and Cheng-Feng Qin. "Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2." Vaccine 32, no. 23 (May 2014): 2675–81. http://dx.doi.org/10.1016/j.vaccine.2014.03.074.
Повний текст джерелаLiu, Xinyu, Xin Zhao, Rui Na, Lili Li, Eberhard Warkentin, Jennifer Witt, Xu Lu, et al. "The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism." Protein & Cell 10, no. 2 (May 11, 2018): 149–53. http://dx.doi.org/10.1007/s13238-018-0551-6.
Повний текст джерелаAdetunji, Shakirat A., Dmitriy Smolensky, Dana N. Mitzel, Jeana L. Owens, Carol G. Chitko-McKown, Natalia Cernicchiaro, and Leela E. Noronha. "In Vitro Infection Dynamics of Japanese Encephalitis Virus in Established Porcine Cell Lines." Pathogens 10, no. 11 (November 12, 2021): 1468. http://dx.doi.org/10.3390/pathogens10111468.
Повний текст джерелаArroyo, Juan, Farshad Guirakhoo, Sabine Fenner, Zhen-Xi Zhang, Thomas P. Monath, and Thomas J. Chambers. "Molecular Basis for Attenuation of Neurovirulence of a Yellow Fever Virus/Japanese Encephalitis Virus Chimera Vaccine (ChimeriVax-JE)." Journal of Virology 75, no. 2 (January 15, 2001): 934–42. http://dx.doi.org/10.1128/jvi.75.2.934-942.2001.
Повний текст джерелаXin, Yu Yong, Ao Jian, Guo Yu Peng, Li Ho Min, and Zhang Guo Ming. "Safety of a Live-Attenuated Japanese Encephalitis Virus Vaccine (SA14-14-2) for Children." American Journal of Tropical Medicine and Hygiene 39, no. 2 (August 1, 1988): 214–17. http://dx.doi.org/10.4269/ajtmh.1988.39.214.
Повний текст джерелаHennessy, S., B. L. Strom, W. B. Bilker, L. Zhengle, W. Chao-Min, L. Hui-Lian, W. Tai-Xiang, et al. "Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study." Lancet 347, no. 9015 (June 1996): 1583–86. http://dx.doi.org/10.1016/s0140-6736(96)91075-2.
Повний текст джерелаLi, Guohua, Hongli Jin, Xin Nie, Yongkun Zhao, Na Feng, Zongxi Cao, Shuyi Tan, et al. "Development of a reverse genetics system for Japanese encephalitis virus strain SA14-14-2." Virus Genes 55, no. 4 (June 3, 2019): 550–56. http://dx.doi.org/10.1007/s11262-019-01674-y.
Повний текст джерелаLi, Xiao-Feng, Wei Zhao, Fang Lin, Qing Ye, Hong-Jiang Wang, Dong Yang, Shi-Hua Li, et al. "Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2." Journal of General Virology 94, no. 12 (December 1, 2013): 2700–2709. http://dx.doi.org/10.1099/vir.0.059436-0.
Повний текст джерелаSohn, Young Mo, Min Soo Park, Hye Ok Rho, Laura J. Chandler, Robert E. Shope, and Theodore F. Tsai. "Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants." Vaccine 17, no. 18 (May 1999): 2259–64. http://dx.doi.org/10.1016/s0264-410x(99)00006-7.
Повний текст джерелаLiu, Xinyu, Danhua Zhao, Lili Jia, Hongshan Xu, Rui Na, Yonghong Ge, Shaoxiang Liu, Yongxin Yu, and Yuhua Li. "Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus." Vaccine 36, no. 31 (July 2018): 4650–56. http://dx.doi.org/10.1016/j.vaccine.2018.06.040.
Повний текст джерелаHong, Sun Pyo, Wang-Don Yoo, Robert Putnak, Kenneth H. Eckels, Hyune Mo Rho, and Soo-Ok Kim. "Nucleotide Sequence of Envelope Protein of Japanese Encephalitis Virus SA14-14-2 Adapted to Vero Cells." DNA Sequence 12, no. 5-6 (January 2001): 437–42. http://dx.doi.org/10.3109/10425170109084471.
Повний текст джерелаLi, Shi-Hua, Xiao-Feng Li, Hui Zhao, Yong-Qiang Deng, Xue-Dong Yu, Shun-Ya Zhu, Tao Jiang, Qing Ye, E.-De Qin, and Cheng-Feng Qin. "Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2." Virology Journal 10, no. 1 (2013): 64. http://dx.doi.org/10.1186/1743-422x-10-64.
Повний текст джерелаChambers, Thomas J., Ann Nestorowicz, Peter W. Mason, and Charles M. Rice. "Yellow Fever/Japanese Encephalitis Chimeric Viruses: Construction and Biological Properties." Journal of Virology 73, no. 4 (April 1, 1999): 3095–101. http://dx.doi.org/10.1128/jvi.73.4.3095-3101.1999.
Повний текст джерелаErra, Elina O., and Anu Kantele. "The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis." Expert Review of Vaccines 14, no. 9 (July 10, 2015): 1167–79. http://dx.doi.org/10.1586/14760584.2015.1061939.
Повний текст джерелаSohn, Young Mo. "Primary and Booster Immune Responses to Live Attenuated SA14-14-2 Japanease Encephalitis Vaccine in Korean Infants." Korean Journal of Pediatric Infectious Diseases 5, no. 1 (1998): 67. http://dx.doi.org/10.14776/kjpid.1998.5.1.67.
Повний текст джерелаYu, Yongxin. "Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities." Vaccine 28, no. 21 (May 2010): 3635–41. http://dx.doi.org/10.1016/j.vaccine.2010.02.105.
Повний текст джерелаYun, Sang-Im, Byung-Hak Song, Irina A. Polejaeva, Christopher J. Davies, Kenneth L. White, and Young-Min Lee. "Comparison of the live-attenuated Japanese encephalitis vaccine SA14 -14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo." Journal of General Virology 97, no. 10 (October 13, 2016): 2575–91. http://dx.doi.org/10.1099/jgv.0.000574.
Повний текст джерелаWang, Ran, Meng Zhang, Linlin Zhang, Mengjia Liu, Chao Shan, Jing An, and Zhengde Xie. "Japanese Encephalitis Vaccine Generates Cross-Reactive Memory T Cell Responses to Zika Virus in Humans." Journal of Tropical Medicine 2022 (November 19, 2022): 1–10. http://dx.doi.org/10.1155/2022/8379286.
Повний текст джерелаMonath, T. P., I. Levenbook, K. Soike, Z. X. Zhang, M. Ratterree, K. Draper, A. D. T. Barrett, et al. "Chimeric Yellow Fever Virus 17D-Japanese Encephalitis Virus Vaccine: Dose-Response Effectiveness and Extended Safety Testing in Rhesus Monkeys." Journal of Virology 74, no. 4 (February 15, 2000): 1742–51. http://dx.doi.org/10.1128/jvi.74.4.1742-1751.2000.
Повний текст джерелаMonath, Thomas P., Juan Arroyo, Inessa Levenbook, Zhen-Xi Zhang, John Catalan, Ken Draper, and Farshad Guirakhoo. "Single Mutation in the Flavivirus Envelope Protein Hinge Region Increases Neurovirulence for Mice and Monkeys but Decreases Viscerotropism for Monkeys: Relevance to Development and Safety Testing of Live, Attenuated Vaccines." Journal of Virology 76, no. 4 (February 15, 2002): 1932–43. http://dx.doi.org/10.1128/jvi.76.4.1932-1943.2002.
Повний текст джерелаYang, Jian, Huiqiang Yang, Zhushi Li, Wei Wang, Hua Lin, Lina Liu, Qianzhi Ni, et al. "Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain." Viruses 9, no. 1 (January 21, 2017): 20. http://dx.doi.org/10.3390/v9010020.
Повний текст джерелаTsai, T. F., Yu Yong‐Xin, Jia Li Li, Ravithat Putvatana, Zhang Ran, Wang Shougui, and Scott B. Halstead. "Immunogenicity of Live Attenuated SA14–14–2 Japanese Encephalitis Vaccine—A Comparison of 1–and 3‐Month Immunization Schedules." Journal of Infectious Diseases 177, no. 1 (January 1998): 221–23. http://dx.doi.org/10.1086/517358.
Повний текст джерелаB G, Ranganath. "Incidence of Adverse Events Following Immunization With SA14-14-2 Japanese Encephalitis Vaccine Among Children of 6 to 10Years In Kolar,India." JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES 01, no. 2 (June 15, 2011): 49–54. http://dx.doi.org/10.58739/jcbs/v01i2.2.
Повний текст джерелаFeroldi, Emmanuel, Chitsanu Pancharoen, Pope Kosalaraksa, Kulkanya Chokephaibulkit, Mark Boaz, Claude Meric, Yanee Hutagalung, and Alain Bouckenooghe. "Primary Immunization of Infants and Toddlers in Thailand with Japanese Encephalitis Chimeric Virus Vaccine in Comparison with SA14-14-2." Pediatric Infectious Disease Journal 33, no. 6 (June 2014): 643–49. http://dx.doi.org/10.1097/inf.0000000000000276.
Повний текст джерелаYang, Huan, Fengming Fan, Lina Liu, Jie Liu, Yan Sun, Anping Xie, Xiaoling Shi, et al. "A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain)." Vaccine 38, no. 11 (March 2020): 2636–42. http://dx.doi.org/10.1016/j.vaccine.2020.01.005.
Повний текст джерелаXu, Gaoyuan, Xiaojuan Xu, Zili Li, Qigai He, Bin Wu, Shengfu Sun, and Huanchun Chen. "Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity." Vaccine 22, no. 15-16 (May 2004): 1846–53. http://dx.doi.org/10.1016/j.vaccine.2003.09.015.
Повний текст джерелаLiu, Zheng‐Le, Sean Hennessy, Brian L. Strom, Theodore F. Tsai, Chao‐Min Wan, Sheng‐Cai Tang, Cheng‐Fa Xiang, et al. "Short‐Term Safety of Live Attenuated Japanese Encephalitis Vaccine (SA14–14–2): Results of a Randomized Trial with 26,239 Subjects." Journal of Infectious Diseases 176, no. 5 (November 1997): 1366–69. http://dx.doi.org/10.1086/517323.
Повний текст джерелаChambers, Thomas J., Deborah A. Droll, Xiaoshan Jiang, William S. M. Wold, and Janice A. Nickells. "JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: Biological properties in the mouse model of neuroinvasive disease." Virology 366, no. 1 (September 2007): 51–61. http://dx.doi.org/10.1016/j.virol.2007.04.016.
Повний текст джерелаLiu, Xinyu, Yongxin Yu, Maoguang Li, Guodong Liang, Huanyu Wang, Lili Jia, and Guanmu Dong. "Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China." Vaccine 29, no. 11 (March 2011): 2127–30. http://dx.doi.org/10.1016/j.vaccine.2010.12.108.
Повний текст джерелаSong, Byung-Hak, Gil-Nam Yun, Jin-Kyoung Kim, Sang-Im Yun, and Young-Min Lee. "Biological and genetic properties of SA14-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans." Journal of Microbiology 50, no. 4 (August 2012): 698–706. http://dx.doi.org/10.1007/s12275-012-2336-6.
Повний текст джерелаWang, Hong-Jiang, Long Liu, Xiao-Feng Li, Qing Ye, Yong-Qiang Deng, E.-De Qin, and Cheng-Feng Qin. "In vitro and in vivo characterization of chimeric duck Tembusu virus based on Japanese encephalitis live vaccine strain SA14-14-2." Journal of General Virology 97, no. 7 (July 1, 2016): 1551–56. http://dx.doi.org/10.1099/jgv.0.000486.
Повний текст джерелаYang, Huiqiang, Zhushi Li, Hua Lin, Wei Wang, Jian Yang, Lina Liu, Xianwu Zeng, Yonglin Wu, Yongxin Yu, and Yuhua Li. "A novel dengue virus serotype 1 vaccine candidate based on Japanese encephalitis virus vaccine strain SA14-14-2 as the backbone." Archives of Virology 161, no. 6 (March 15, 2016): 1517–26. http://dx.doi.org/10.1007/s00705-016-2817-8.
Повний текст джерелаNikam, Bhushan Sanjay, Anurag kalia, Suvechchha Pandit, and Nimesh Gupta. "Ablation of regulatory T cells lead to compromised quality of humoral immunity to SA14-14-2 live attenuated Japanese encephalitis vaccine." Journal of Immunology 210, no. 1_Supplement (May 1, 2023): 158.02. http://dx.doi.org/10.4049/jimmunol.210.supp.158.02.
Повний текст джерелаTurtle, Lance, Filippo Tatullo, Tanushka Bali, Vasanthapuram Ravi, Mohammed Soni, Sajesh Chan, Savita Chib, et al. "Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area." PLOS Neglected Tropical Diseases 11, no. 1 (January 30, 2017): e0005263. http://dx.doi.org/10.1371/journal.pntd.0005263.
Повний текст джерелаNath, Barnali, Ashutosh Gupta, Siraj A. Khan, and Sachin Kumar. "Enhanced cytopathic effect of Japanese encephalitis virus strain SA14-14-2: Probable association of mutation in amino acid of its envelope protein." Microbial Pathogenesis 111 (October 2017): 187–92. http://dx.doi.org/10.1016/j.micpath.2017.08.046.
Повний текст джерелаSricharoenchai, Sirintip, Keswadee Lapphra, Sunate Chuenkitmongkol, Wanatpreeya Phongsamart, Alain Bouckenooghe, Orasri Wittawatmongkol, Supattra Rungmaitree, and Kulkanya Chokephaibulkit. "Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination With Live Attenuated SA14-14-2 Vaccine." Pediatric Infectious Disease Journal 36, no. 2 (February 2017): e45-e47. http://dx.doi.org/10.1097/inf.0000000000001395.
Повний текст джерелаLi, Zhushi, Huiqiang Yang, Jian Yang, Hua Lin, Wei Wang, Lina Liu, Yu Zhao, et al. "Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone." Virus Research 191 (October 2014): 10–20. http://dx.doi.org/10.1016/j.virusres.2014.07.017.
Повний текст джерелаJanewongwirot, Pakpoom, Thanyawee Puthanakit, Suvaporn Anugulruengkitt, Watsamon Jantarabenjakul, Chayapa Phasomsap, Sompong Chumket, Sutee Yoksan, and Chitsanu Pancharoen. "Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children." Vaccine 34, no. 44 (October 2016): 5279–83. http://dx.doi.org/10.1016/j.vaccine.2016.09.005.
Повний текст джерелаWang, Ran, Dongying Fan, Lei Wang, Yueqi Li, Hongning Zhou, Na Gao, and Jing An. "Neutralizing antibody rather than cellular immune response is maintained for nearly 20 years among Japanese encephalitis SA14-14-2 vaccinees in an endemic setting." Infection, Genetics and Evolution 85 (November 2020): 104476. http://dx.doi.org/10.1016/j.meegid.2020.104476.
Повний текст джерелаYamshchikov, Vladimir, Marina Manuvakhova, and Efrain Rodriguez. "Development of a human live attenuated West Nile infectious DNA vaccine: Suitability of attenuating mutations found in SA14-14-2 for WN vaccine design." Virology 487 (January 2016): 198–206. http://dx.doi.org/10.1016/j.virol.2015.10.015.
Повний текст джерелаWang, Ran, Zida Zhen, Lance Turtle, Baohua Hou, Yueqi Li, Na Wu, Na Gao, Dongying Fan, Hui Chen, and Jing An. "T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine." Applied Microbiology and Biotechnology 104, no. 15 (June 15, 2020): 6779–89. http://dx.doi.org/10.1007/s00253-020-10710-z.
Повний текст джерелаZheng, Xiaoyan, Xiaozheng Yu, Yan Wang, Min Cui, Ran Wang, and Chenghong Yin. "Immune responses and protective effects against Japanese encephalitis induced by a DNA vaccine encoding the prM/E proteins of the attenuated SA14-14-2 strain." Infection, Genetics and Evolution 85 (November 2020): 104443. http://dx.doi.org/10.1016/j.meegid.2020.104443.
Повний текст джерелаCalvert, Amanda E., Kandice L. Dixon, Mark J. Delorey, Carol D. Blair, and John T. Roehrig. "Development of a small animal peripheral challenge model of Japanese encephalitis virus using interferon deficient AG129 mice and the SA14-14-2 vaccine virus strain." Vaccine 32, no. 2 (January 2014): 258–64. http://dx.doi.org/10.1016/j.vaccine.2013.11.016.
Повний текст джерелаWills, Mark R., Bijon K. Sil, Jing X. Cao, Y. X. Yu, and Alan D. T. Barrett. "Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area." Vaccine 10, no. 12 (January 1992): 861–72. http://dx.doi.org/10.1016/0264-410x(92)90051-k.
Повний текст джерела